XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.20

-1.7%

1:12 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (9530)	4/5/1999 7:06:00 AM
From: Robert K.	Read Replies (1) of 17367

I dare say that the zero deaths hypothesis is possible but unlikely for the mere fact it might be impossible to justify the trial length if so. I have excluded it as a possibility because I dont want to think about it. Regarding magainin, I remember the Discover article. The problem they had with production(I think) was how do you make a peptide that kills bacteria through production in bacteria, without killing the bacteria trying to produce it. The animal method would circumvent that problem. However, I think X has production capabilty anyways. Standard K disclaimers.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next